The expression level of CD44 in 4T1 breast cancer cells was substantially higher than that in undifferentiated bone marrow-derived macrophages (M0-BMDMs), naive CD8+ T cells, and activated CD8+ T cells (Supplementary Fig. 6). This evidence concerns the gene CD8A and breast carcinoma.